Login / Signup

High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag.

Kohei HosokawaHirohito YamazakiMikoto TanabeTatsuya ImiNaomi SugimoriShinji Nakao
Published in: Leukemia (2020)
Keyphrases
  • high dose
  • stem cell transplantation
  • low dose
  • chronic kidney disease
  • iron deficiency
  • allogeneic hematopoietic stem cell transplantation
  • acute lymphoblastic leukemia